REG - Iconic Labs PLC - Transaction Terminated

Iconic LabsAnnouncement

13/02/2025 18:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250213:nRSM0860Xa&default-theme=true

RNS Number : 0860X  Iconic Labs PLC  13 February 2025

 

Iconic Labs PLC

("Iconic" or the "Company")

Transaction Terminated

 

On 11 March 2024 the Company entered into a non-binding heads of terms with
the owners of ITS Holdings 2023 Ltd (the "Target"), the holder of the entire
issued share capital of In the Style Fashion Ltd, an online fashion retailer,
in connection with the potential purchase of the entire issued share capital
of the Target ("Transaction").

The Board wishes to announce that the Transaction, which would have
constituted a reverse takeover under the UK Listing Rules, will not proceed to
conclusion.

The Directors of Iconic are now assessing alternative transactions and will
make an announcement in due course.

The Directors will now request that the Financial Conduct Authority the
restoration of the Company's listing on the Official List and to trading on
the Main Market of the London Stock Exchange.

This announcement contains information which, prior to its disclosure, was
inside information as stipulated under Regulation 11 of the Market Abuse
(Amendment) (EU Exit) Regulations 2019/310 (as amended).

- ENDS -

For more information, please contact:

 Iconic Labs                                         via Yellow Jersey PR

 John Farquharson, Interim Chief Executive Officer
 Novum Securities Limited                            Tel: +44 (0) 20 7399 9400

 David Coffman / Daniel Harris
 Yellow Jersey PR                                    Tel: +44 (0) 20 3004 9512

 Charles Goodwin

 Annabelle Wills                                     iconic@yellowjerseypr.com

 Bessie Elliot

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCKZGMZNFDGKZM